-
Synthesis technology of cepharanthine, a "specific drug" for coronavirus
Industry Data
PharmaSources/YuntianMay 25, 2022
Recently, cepharanthine, first discovered in China as the new drug for treating COVID-19, has recently been granted the national invention patent authorization, which has drawn great attention from inside and outside the industry.
-
New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies
Industry Data
PharmaSources/YefenghongMay 25, 2022
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
-
Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"?
Industry Data
PharmaSources/YefenghongMay 23, 2022
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
-
The Oral Vaccine Market and Technology
Industry Data
PharmaSources/David OrchardMay 12, 2022
A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.
-
Breakthrough in Research of Small Molecule Drugs against SARS-CoV-2
Industry Data
PharmaSources/XiaonishaMarch 21, 2022
Corona virus disease 2019 (COVID-19) caused by a novel single-stranded RNA coronavirus has swept the world. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-2.
-
To Win the Fight against COVID-19 in the Future, How To Make a Breakthrough in the R&D of New Drug?
Industry Data
PharmaSources/Professor in medical fieldMarch 21, 2022
Recently, with the continuous evolution and spread of Novel Coronavirus variant (including Delta-related variant viruses) all over the world, the mortality rate in some areas has a tendency to increase.
-
Weekly Pharmaceutical News Review | PharmaSources.com (Feb. 28th to March.4th)
Industry Data
PharmaSources.comMarch 16, 2022
The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
-
Africa Expands Vaccine Manufacturing Capacity
Features
Shem OirereMarch 08, 2022
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
-
FDA Stops Two COVID-19 Rapid Diagnostics Tests
Features
Lin ZhangMarch 01, 2022
The coronavirus (COVID-19) pandemic has been around for more than two years. While in many ways the world is returning to normal, the wave of Omicron and continued cases of COVID-19 still need to be addressed.
-
Increased COVID-19 testing triggers demand for kit reagents
Features
Shem OirereFebruary 22, 2022
The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.
Recently, cepharanthine, first discovered in China as the new drug for treating COVID-19, has recently been granted the national invention patent authorization, which has drawn great attention from inside and outside the industry.
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.
Corona virus disease 2019 (COVID-19) caused by a novel single-stranded RNA coronavirus has swept the world. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-2.
Recently, with the continuous evolution and spread of Novel Coronavirus variant (including Delta-related variant viruses) all over the world, the mortality rate in some areas has a tendency to increase.
The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
The coronavirus (COVID-19) pandemic has been around for more than two years. While in many ways the world is returning to normal, the wave of Omicron and continued cases of COVID-19 still need to be addressed.
The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.
Pharma Sources Insight JUNE2022
